Ali led the investment, and Tencent increased its stake. Brain-computer interface company "Jieti Medical" received a strategic financing of 500 million yuan | First release by 36Kr
36Kr learned that the brain-computer interface company "Jieti Medical" recently received a strategic financing of 500 million yuan, led by Alibaba and followed by SDIC Chuanghe. Existing shareholders such as Tencent, Yuanlai Capital, OrbiMed, Yuanhe Origin, Qiming Venture Partners, Lilly Asia Ventures, Source Code Capital, and Shanghai SDIC Leading continued to participate. Qifeng Capital served as the exclusive financial advisor. In the past year, the cumulative financing amount of Jieti Medical reached 1.1 billion yuan.
In December 2025, Jieti Medical released its second-generation high-throughput wireless invasive brain-computer interface system (WRS02), with the number of electrode channels increased to 256. In addition to "motion control", its application scenarios will also be expanded to "language reconstruction". 36Kr once published a detailed interview.
At the beginning of 2026, with the help of its self-developed surgical robot, Jieti Medical completed the clinical implantation of its 256-channel brain-computer interface system and verified the effectiveness of the brain-control interaction function. In 2026, Jieti Medical will conduct multi-center registered clinical trials of brain-computer interfaces and plans to complete the enrollment and implantation surgeries of about 40 patients within the year.
The year 2026 may be a watershed for brain-computer interfaces. While the technology and system are being implemented, on the payment side, in 2025, the National Healthcare Security Administration issued the "Guidelines for the Establishment of Medical Service Price Items for Nervous System Diseases (Trial)", which established multiple services of brain-computer interfaces as independent charging items, demonstrating the determination of multiple parties to support the implementation of the brain-computer interface industry.
Zhao Zhengtao, the founder of Jieti Medical, once said in an interview with 36Kr, "In the next three to five years, the clinical value of brain-computer interface in treating diseases will definitely be verified, that is, improving the quality of life and work ability of patients. In the next five to ten years, the consumer medical attributes of brain-computer interfaces will begin to emerge. It has communication attributes and is an information bridge for interaction between humans and machines, which can transform the way of human-machine interaction and improve efficiency."
For the brain-computer interface platform, on the basis of ultra-flexible neural electrodes, full-system development, and clinical trial verification, the level of research and understanding of the brain by neuroscience determines the ceiling of future brain-computer interface development.
In this process, "In the future, whoever masters more massive brain science data will be closer to the right to define new application scenarios and technical paths. After a large amount of data is accumulated in a single brain region and for a single task, a 'base model' can be trained through brain data like a large model. This base model can be applied to future new patients, greatly improving the initial performance of their decoders and brain-control performance."
In this investment in Jieti Medical by Internet and technology giants such as Alibaba, their accumulation in multi-modal large models, computing power bases, intelligent hardware, and ecological deployment may be integrated with Jieti Medical's hardware barriers in brain-computer interfaces and clinical transformation experience in the future to build a "new-generation intelligent brain-computer interface system and a rich and cutting-edge application ecosystem".
It is reported that at the beginning of researching brain-computer interface technology, Jieti Medical envisioned applying this technology to consumer-level scenarios in the future. The reason for starting with medical applications is that medical is a necessary path. It can not only meet the actual needs of many people but also drive the team to continuously refine various technologies.
"In this process, we hope not only to restore the motor ability and sensory perception of patients but also to help patients explore the boundaries of human control. In the past, we used our brains to control our limbs. In the future, we will use brain-computer interfaces to control external devices. Where are its boundaries? Can it exceed the current human level? I believe it can." Li Xue, the founder of Jieti Medical, said. Currently, paralyzed patients with implanted brain-computer interfaces have certain comparative advantages in specific tasks such as cursor control speed after training.
In the future, when brain-computer interfaces are linked with the rapidly developing artificial intelligence and software and hardware technologies, it will be possible to efficiently and complexly control intelligent agent devices through brain thoughts. In Jieti Medical's vision, "By then, through brain-computer interfaces, the brain can be integrated with various external devices, and the era of 'human-machine integration' will truly arrive and be smoothly applied to thousands of households."